Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Thirunavukkarasu Sathish, Robyn Tapp, Mark E. Cooper, Paul Zimmet

Research output: Contribution to journalComment/debatepeer-review

4 Citations (Scopus)

Abstract

The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.
Original languageEnglish
Article number101204
JournalDiabetes and Metabolism
Volume47
Issue number2
Early online date28 Oct 2020
DOIs
Publication statusPublished - Mar 2021

Keywords

  • COVID-19
  • Coronavirus
  • Incident diabetes
  • Inflammation
  • Insulin resistance
  • Insulin secretion
  • New-onset diabetes
  • Metabolism
  • Type 1 diabetes
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes'. Together they form a unique fingerprint.

Cite this